Abstract
Among skin cancers, melanoma presents the highest letality, despite its relatively low incidence. Different from every other tumor, melanoma incidence is increasing at a very high rate in the last 20 years. When diagnosed at late stages, melanoma seems resistant to chemotherapy. The molecular bases of such chemoresistance are now being unveiled, opening new perspectives for the treatment …